Oncolytic Virotherapy for Multiple Myeloma Using a Tumour-Specific Double-Deleted Vaccinia Virus

Leukemia - United Kingdom
doi 10.1038/leu.2008.120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Oncolytic Virotherapy as an Immunotherapeutic Strategy for Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2017English

Oncolytic Virotherapy

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Tumour-Specific Triple-Regulated Oncolytic Herpes Virus to Target Glioma

Oncotarget
Oncology
2016English

Oncolytic Measles Virus Therapy Enhances Tumor Antigen-Specific T-Cell Responses in Patients With Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2020English

Oncolytic Potency and Reduced Virus Tumor-Specificity in Oncolytic Virotherapy. A Mathematical Modelling Approach

PLoS ONE
Multidisciplinary
2017English

Improved Oncolytic Virotherapy by Increasing Virus Spread Within Tumors.

English

Systemic Therapy With Oncolytic Myxoma Virus Cures Established Residual Multiple Myeloma in Mice

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans

Cancer Research
Cancer ResearchOncology
2013English

Oncolytic Virotherapy for Human Malignant Mesothelioma: Recent Advances

Oncolytic Virotherapy
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy